Summit Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Buy
4,931
+1,504
+44% +$494K 0.02% 664
2025
Q4
$1.2M Buy
3,427
+599
+21% +$202K 0.02% 605
2025
Q3
$914K Buy
+2,828
New +$880K 0.01% 679

Other funds holding ELV

Summit Financial's ELV Position: Q1 2026 in Review

Summit Financial increased its Elevance Health (ELV) stake by 44% in Q1 2026, buying an estimated $494K and bringing the position to 4,931 shares worth $1.44M. The position accounts for 0.02% of the portfolio, ranked #664.

Summit Financial first reported a position in ELV in Q3 2025 and has held it in 3 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Summit Financial held 4,931 shares of Elevance Health worth $1.44M as of Q1 2026.
  • Summit Financial bought 1,504 Elevance Health shares in Q1 2026, an estimated $494K.
  • Elevance Health made up 0.02% of Summit Financial's portfolio in Q1 2026, its #664 holding.
  • Summit Financial first reported a position in Elevance Health in Q3 2025 and has held it in 3 quarters since.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.